Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2015
Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents
E D Saad, M Buyse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 8, 2016
Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'
E D Saad, M Buyse
Revista Do Hospital Das Clinicas
|
January 1, 1996
[Evidence-based medicine]
E D Saad, H Grunspun
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2008
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined
E D Saad, A Katz
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy
E D Saad, M Buyse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2018
Avoiding the hazards of misinterpreting treatment effects
E D Saad, I F Tannock
Oncology (Williston Park, N.Y.)
|
February 28, 2001
Other fluorinated pyrimidines in the treatment of solid tumors
E D Saad, P M Hoff
Japanese Journal of Clinical Oncology
|
June 2, 2001
Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1
S A Elasmar, E D Saad, P M Hoff
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?
J Bines, H Earl, A C Buzaid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2009
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
E D Saad, A Katz, P M Hoff, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2015
Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents
E D Saad, M Buyse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 8, 2016
Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'
E D Saad, M Buyse
Revista Do Hospital Das Clinicas
|
January 1, 1996
[Evidence-based medicine]
E D Saad, H Grunspun
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2008
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined
E D Saad, A Katz
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy
E D Saad, M Buyse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2018
Avoiding the hazards of misinterpreting treatment effects
E D Saad, I F Tannock
Oncology (Williston Park, N.Y.)
|
February 28, 2001
Other fluorinated pyrimidines in the treatment of solid tumors
E D Saad, P M Hoff
Japanese Journal of Clinical Oncology
|
June 2, 2001
Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1
S A Elasmar, E D Saad, P M Hoff
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?
J Bines, H Earl, A C Buzaid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2009
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
E D Saad, A Katz, P M Hoff, et al.
Page
of 2